Dana Dickens

Senior Director, Trade at Gilead Sciences

Speaker

Dana Dickens serves as Head of Channel Accounts, where she leads the strategic account management for the distribution of Gilead’s commercial products across all therapeutic areas. In this role, Dana oversees the account management team, drives strategic planning, and ensures the effective delivery of Gilead therapies to patients.

Since joining Gilead in May 2020, Dana has brought deep expertise in designing and executing pharmaceutical distribution channel strategies. Her extensive background in the Specialty Pharmacy space spans both manufacturer and pharmacy perspectives, enabling her to deliver comprehensive and innovative solutions.

Prior to Gilead, Dana was Director of Trade & Distribution for the Specialty Pharmacy channel at Sobi, where she led strategic development and operational execution across four rare disease products. Her earlier experience includes her tenure at Novartis, where she focused on developing Enhanced Service Programs to improve patient outcomes. Dana also served as Senior Director of Pharmacy Relations and Business Development at AcariaHealth, a leading payer-owned Specialty Pharmacy, and has held roles in National Accounts, Market Development, Business Development, and Sales.

Dana is a recognized thought leader in the industry and a frequent speaker at Trade and Channel Strategy conferences. She is also a passionate advocate and board member of Tina’s Warriors, as well as a board member of Vantage Point Logistics.